ZA969139B - Pure 3R-3'R stereoisomer of zeaxanthin for treating macular degeneration in humans. - Google Patents

Pure 3R-3'R stereoisomer of zeaxanthin for treating macular degeneration in humans.

Info

Publication number
ZA969139B
ZA969139B ZA9609139A ZA969139A ZA969139B ZA 969139 B ZA969139 B ZA 969139B ZA 9609139 A ZA9609139 A ZA 9609139A ZA 969139 A ZA969139 A ZA 969139A ZA 969139 B ZA969139 B ZA 969139B
Authority
ZA
South Africa
Prior art keywords
zeaxanthin
stereoisomer
humans
pure
macular degeneration
Prior art date
Application number
ZA9609139A
Other languages
English (en)
Inventor
Kevin M Garnett
Dennis L Gierhart
Luis H Guerra-Santos
Original Assignee
Applied Food Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/551,153 external-priority patent/US5827652A/en
Priority claimed from US08/551,166 external-priority patent/US5854015A/en
Application filed by Applied Food Biotech Inc filed Critical Applied Food Biotech Inc
Publication of ZA969139B publication Critical patent/ZA969139B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA9609139A 1995-10-31 1996-10-30 Pure 3R-3'R stereoisomer of zeaxanthin for treating macular degeneration in humans. ZA969139B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/551,153 US5827652A (en) 1995-10-31 1995-10-31 Zeaxanthin formulations for human ingestion
US08/551,166 US5854015A (en) 1995-10-31 1995-10-31 Method of making pure 3R-3'R stereoisomer of zeaxanthin for human ingestion

Publications (1)

Publication Number Publication Date
ZA969139B true ZA969139B (en) 1997-09-25

Family

ID=27069666

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9609139A ZA969139B (en) 1995-10-31 1996-10-30 Pure 3R-3'R stereoisomer of zeaxanthin for treating macular degeneration in humans.

Country Status (14)

Country Link
JP (1) JPH10512594A (zh)
KR (1) KR100570251B1 (zh)
CN (1) CN1104235C (zh)
AR (1) AR004245A1 (zh)
AU (1) AU710634B2 (zh)
BR (1) BR9611488A (zh)
CZ (1) CZ297575B6 (zh)
FI (1) FI980947A (zh)
HU (1) HU223208B1 (zh)
NO (1) NO981698L (zh)
PL (1) PL185465B1 (zh)
RU (1) RU2197958C2 (zh)
WO (1) WO1997016175A1 (zh)
ZA (1) ZA969139B (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8088363B2 (en) 2002-10-28 2012-01-03 Zeavision Llc Protection against sunburn and skin problems with orally-ingested high-dosage zeaxanthin
GB0501365D0 (en) 2005-01-21 2005-03-02 Promar As Compositions
AU2006213635B2 (en) * 2005-02-11 2010-06-17 Kalamazoo Holdings, Inc. A Capsicum variety exhibiting a hyper-accumulation of zeaxanthin and products derived therefrom
US8592662B2 (en) 2005-02-11 2013-11-26 Kalamazoo Holdings, Inc. Capsicum variety exhibiting a hyper-accumulation of zeaxanthin and products derived therefrom

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US308759A (en) * 1884-12-02 Curling hat-brims and machine therefor
DK0534955T3 (da) * 1989-08-30 1997-10-13 Applied Food Biotech Inc Fremgangsmåde til fremstilling af en zeaxanthinholdig sammensætning under anvendelse af en mikroorganisme af arten Flavobacterium multivorum.
US5310764A (en) * 1992-05-08 1994-05-10 Steven Baranowitz Treatment of age related macular degeneration with beta-carotene

Also Published As

Publication number Publication date
HUP9802314A2 (hu) 1999-04-28
PL185465B1 (pl) 2003-05-30
KR100570251B1 (ko) 2006-06-21
AU710634B2 (en) 1999-09-23
CZ130998A3 (cs) 1998-07-15
FI980947A0 (fi) 1996-10-30
PL326558A1 (en) 1998-09-28
HUP9802314A3 (en) 1999-05-28
HU223208B1 (hu) 2004-03-29
MX9605248A (es) 1998-06-30
CN1104235C (zh) 2003-04-02
CN1201388A (zh) 1998-12-09
RU2197958C2 (ru) 2003-02-10
AU7050196A (en) 1997-05-08
AR004245A1 (es) 1998-11-04
NO981698D0 (no) 1998-04-16
FI980947A (fi) 1998-04-29
KR19990067180A (ko) 1999-08-16
CZ297575B6 (cs) 2007-02-07
JPH10512594A (ja) 1998-12-02
BR9611488A (pt) 1999-01-19
WO1997016175A1 (en) 1997-05-09
NO981698L (no) 1998-06-08

Similar Documents

Publication Publication Date Title
IL117793A0 (en) Method for the treatment of macular degeneration
AU5499896A (en) Hair treatment compositions
ZA96740B (en) Skin treatment composition
AU4104896A (en) Stable lycopene concentrates and process for their preparation
ZA966240B (en) Methods for treatment of allergic asthma.
IL116935A0 (en) Venlafaxine for the treatment of hypothalmic amenorrhea
EP1010435A4 (en) PREPARATIONS OF NANOCAPSULES FOR THE TREATMENT OF INTRA-ARTICULAR DISEASES
AU6522396A (en) Composition for cleaning or treating human or animal hair
GB9803642D0 (en) Hair treatment composition
AU4776096A (en) Whey treatment process
AU4792396A (en) Process for the preparation of ethyl-N-(2,3 dichloro-6- nitrobenzyl) glycine
AU2825295A (en) Method for the treatment, prevention or minimization of hair loss
AU3584895A (en) Method of treating macular degeneration using tgf-beta
AU3768795A (en) Method and compositions for hair treatment
SG60050A1 (en) Process for the preparation of enantiomerically pure cyclo-alkanl-indol-and azaindol-and pyrimido(1,2a) indol-carbocylic acids and their activated derivatives
AU7678796A (en) Method for the treatment, prevention or minimization of hair loss using a source of fatty acids
ZA969139B (en) Pure 3R-3'R stereoisomer of zeaxanthin for treating macular degeneration in humans.
ZA963019B (en) Process for the preparation of 1,1-difluoroethane
AU4729396A (en) Process for the preparation of 1,2-benzisothiazolin-3-ones
AU2068295A (en) Skin treatment composition
AU3137095A (en) Ophthalmic compositions for treating glaucoma
AU7729096A (en) Oligodendrocyte-specific protein and method for treating disease
IL125004A0 (en) Process for the preparation of 9,11 beta-epoxide steroids
AU697136B2 (en) Agents for treating metabolic bone diseases
AU6662794A (en) Composition for the treatment of impaired hair growth